Skip navigation
CBI
The Leader in Conferences for the Pharmaceutical Industry

CBI’s 2nd Annual Bio/Pharmaceutical Conference on New Product Forecasting

Develop Innovative Forecasting Models to Mitigate Risk and Ensure Accurate Market Projections

June 26, 2012 - June 27, 2012
  • Philadelphia, Pennsylvania

Distinguished Speakers

Bob Falcon

Associate Director, Business Development and Pipeline Forecasting, Specialty Generics and Devices
Endo Pharmaceuticals

Diane Waters

New Product Planning Cardiometabolic Senior Manager, Market Research
Daiichi Sankyo

Don Miners

Associate Director, Strategic Forecasting
Endo Pharmaceuticals

Ethan Buckley

Associate Director, New Product Analysis
Astellas Pharma US, Inc.

Gary Johnson

Managing Director
Inpharmation Ltd.

Jerry A. Rosenblatt Ph.D.

Partner
Foster Rosenblatt

Kim Slocum

President
KDS Consulting

Leo MacDonald

Director, Global Strategic Analytics
Johnson & Johnson

Michael Epstein

Director and Practice Leader, Commercial Strategy Practice
UBC

Michael Polster Ph.D.

Senior Vice President, Healthcare Practice
National Analysts Worldwide

Peter Edinburg

Former Associate Director, Forecasting
Optimer Pharmaceuticals

Shacker Mourad R.Ph, MBA

President, NoahsPharm; Leadership Communication Instructor, University of Pennsylvania, Wharton Business School; Staff In-Patient Pharmacist, Veterans Administration; Adjunct Professor, Pharmaceutical and Healthcare Marketing
University of the Sciences in Philadelphia

Stephen Fleming

Principal
Trinity Partners, LLC

Thomas Foster Ph.D.

Partner
Foster Rosenblatt

Zhen Tang

(Former) Director, Global Business Intelligence, Bristol-Myers Squibb; President
Asight